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Correlation between protein kinase C activity and histopathological
criteria in human colorectal adenoma
M. Kusunoki, T. Hatada, Y. Sakanoue, H. Yanagi & J. Utsunomiya
The Second Department ofSurgery, Hyogo College ofMedicine, Japan.
Summary We examined protein kinase C (PKC) activity in the cytosolic and particulate fractions of
homogenates obtained from 25 colorectal adenomas and adjacent normal mucosa in patients with colorectal
carcinoma. The total PKC activity of colorectal adenomas was significantly reduced compared with that of
normal mucosa in all cases (122 ± 45.8 vs 174 ± 50.5 pmol min- mg-') (means ± s.d.) (P<0.001). The
particulate fraction PKC activity of adenomas was also significantly lower than in normal mucosa (71.4 ± 31.3
vs 115 ± 39.6 pmol min-' mg-') (P<0.O01).
Adenomas were classified by size, histological type and degree of dysplasia. The average particulate PKC
activity ratio (adenoma/normal mucosa) of tubulovillous adenomas or those with severe dysplasia was
significantly reduced compared with that of tubular adenomas or tumours with mild and moderate dysplasia
(both P<0.001), while there were no significant differences in the cytosolic PKC activity ratio.
The particulate PKC activity ratio decreased significantly with increasing adenoma size (P<0.001), while the
cytosolic ratio again showed no difference.
These findings suggested that the particulate PKC activity ratio had a possible correlation with the
malignant potential of colorectal adenomas and that this ratio may be a useful biological indicator of
colorectal carcinogenesis.
Protein kinase C (PKC) is a serine/threonine-specific protein
kinase, the activity of which is dependent upon Ca2" and
phospholipid (Takai et al., 1979; Nishizuka, 1984). This
enzyme is ubiquitous in eukaryotes (Kuo et al., 1980) and
appears to play a key role in transmembrane signaling
(Nishizuka, 1986). PKC is activated by 1,2-diacylglycerol,
which is formed in response to extracellular signals by the
turnover of phosphoinositides (Berridge & Irvine, 1984) and
other membrane phospholipids (Lacal et al., 1987). This
activation process involves translocation of cytosolic PKC to
the plasma membrane, which in turn leads to the phosphory-
lation of target molecules, thereby influencing important
cellular processes such as proliferation and/or differentiation
(Weinstein, 1987). It has also been suggested that alterations
in PKC activity may play a role in the early stages of
malignant transformation (Ashendel, 1985).
Kopp et al. showed that in vitro membrane-bound PKC
activity was reduced in colonic adenomas and carcinomas
when compared to the adjacent normal colonic mucosa,
suggesting that alterations within the PKC pathway occurred
as an early event in the adenoma-carcinoma sequence (Kopp
et al., 1991).
The purpose of this study was to investigate the PKC
activity of colorectal adenomas in comparison with their
clinicopathological findings to determine whether or not
activation of PKC was a useful biological marker of colonic
tumorigenesis.
Materials and methods
Materials and chemicals
ATP, bovine serum albumin (fatty acid-free) Hepes, histone
III-s, phenylmethylsulfonyl fluoride, leupeptin, phosphatidyl
serine, and diolein were obtained from Sigma (St Louis,
MO). [-` 32P] ATP was purchased from ICN (Costa Mesa,
CA). Phosphocellulose paper (grade P-81) was obtained
from Whatman (Clifton, NJ). All other materials used were
obtained from commercial sources.
Sample collection
All of the patients gave informed consent for this study and
it was also approved by the College ethics committee. Opera-
tions were performed on 25 patients with adenocarcinoma
and co-existing adenomas (polyps). All operations were per-
formed at the Second Department of Surgery of Hyogo
College of Medicine, between August 1990 and March 1991.
Samples of adenoma tissue and samples of normal mucosa
located about 10 cm from the tumours were quickly removed
and immediately rinsed with cold phosphate-buffered saline.
To ensure that only intact tumour tissue and normal mucosa
were used for analysis, all ulcerated and necrotic tissue was
removed from the tumour specimens and the submucosa and
muscularis were removed from the normal tissue samples.
The specimens had a wet weight ranging from 250-800 mg.
All specimens were sufficiently large to allow the histo-
logical evaluation of tumour tissue adjacent to the tissue
sample subjected to enzyme assay. A histological diagnosis
was made according to the criteria of Morson (Morson et al.,
1979). To assess the degree of tissue heterogeneity, the
amount of each of the following tissue components present
was estimated: stromal elements, nontumorous epithelium,
and tumorous epithelium. For this purpose a grid on the
microscopic field was used (Hennipman et al., 1989) and the
proportion of each tissue element was expressed as a percent-
age of the total. If stromal tissue exceeded 20%, the tumour
was excluded from the study. Tissue samples were frozen in
acetone-dry ice within 30 min of resection and then stored at
-80'C until analysis. The size of adenomas was determined
by measuring the longest diameter.
Preparation ofsubcellularfractionsfrom tissue specimens
All procedures were done at 4'C. The tissues were cut into
small pieces and homogenised in 5 ml of Buffer A (25 mM
Tris-HCI at pH 7.5, 5 mM EDTA, 5 mM ethyleneglycol bis
(B-aminoethylether)-N, N, N', N', -tetra-acetic acid, 0.25 mM
phenylmethylsulfonyl fluoride, 10 ml-' leupeptin, 15 mM 2-
mercaptoethanol, and 0.25 M sucrose) for 1 min at low speed
and then for 5 min at full speed using a Polytron homo-
geniser. Homogenates were centrifuged at 1,000 g for 10min
to remove the nuclear fraction and any unhomogenised tis-
sue. The resultant supernatant was filtered through glass
wool and then centrifuged at 100,000 g for 1 h at 4°C.
The supernatant fraction was then stored at 4°C for use as
the 'cytosolic' fraction, while the pellet was solubilised in
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buffer A containing 1% Triton X-100 (5 ml of Buffer A per
gram of tissue) by continuous stirring for 1 h at 4C.
The solubilised pellet was then centrifuged at 100,000 g for
1 h at 4°C, and the resulting supernatant was used as the
solubilised 'particulate' fraction (Sakanoue et al., 1991b).
Mini DEAE-Sephacel columnpurification
The cytosolic and particulate fractions were further purified
by mini DEAE-Sephacel column chromatography in order to
remove inhibitors of PKC or phosphoprotein phosphatase
(Sakanoue et al., 199la). Fractions containing 2 or 5 mg of
protein were applied to a 0.5 ml mini DEAE-Sephacel col-
umn which was equilibrated in Buffer B (25 mM Tris-HCI at
pH 7.5, 0.5 mM EGTA, 0.5 mM EDTA, and 10 mM 2-mer-
captoethanol).
The column was then washed with 7.5 ml of Buffer B, and
PKC was eluted in 2 ml of Buffer B containing 0.15 M NaCl.
The purified fractions thus obtained were used to determine
the cytosolic and particulate PKC activity, as described
below (Sakanoue et al., 199la).
Peptidephosphorylation assay
PKC activity was assayed as described previously (Sakanoue
et al., 1987). The reaction mixture (20 pl) containing 50 mM
Tris-HCI (pH 7.5) with 15 mM 2-mercaptoethanol, 10 mM
MgC92, 1 mM CaCI2, 8 yg ml-' phosphatidyl serine,
0.8pgmlm' diolein, 5011M [F -_32p] ATP (400-800c.p.m.
pmol-'), and 100mM histone III-s. For control reactions,
phosphatidyl serine and diolein were omitted, and EGTA
was added at a final concentration of 0.5 mm along with the
same volume of phospholipid suspension buffer (20 mM
Tris-HCI at pH 7.5). The protein concentration was
10-40 tg tube-' for cytosolic enzymes and 5-25 g tube-'
for particulate enzymes. Each reaction was conducted at
30°C for 10 min and was terminated onto 2 x 2 cm squares
of P-81 paper. These paper squares were then washed four
times for 2 min each in 75 mM phosphoric acid (10 ml
filter-'), and the radioactivity was determined with a liquid
scintillation counter by counting Cerenkov radiation. PKC
activity was calculated by subtracting the phosphotransferase
activity observed in the presence of EGTA from the activity
observed in the presence of Ca2", phosphatidyl serine, and
diolein.
PKC activity was a linear function of time and protein
with this assay, up to 10 min and 100 pg of protein in both
the cytosolic and particulate fractions of adenoma tissue.
Other techniques
The protein concentration was determined using a Bio Rad
Protein assay kit and bovine serum albumin as the standard
(Bradford, 1976). All experiments were carried out with at
least two tissue preparations and the assays were carried out
in duplicate. Specimens were stained with hematoxylin eosine
according to standard methods for histological examination.
Data are given as the mean ± s.d. and were evaluated by
analysis of variance using the Mann-Whitney U-test. The
likelihood ratio test (chi-square statistic) was used to provide
a statistical assessment of whether adenoma size, histological
type, or degree of dysplasia was an independent risk factor
for the PKC activity ratio, and P values <0.05 were con-
sidered significant.
Results
We examined PKC activity in the cytosolic and particulate
fractions extracted from colonic adenomas and the adjacent
normal mucosa. The total PKC activity in the adenomas was
significantly lower than that in the normal mucosa
(122 ± 45.8 vs 174 ± 50.5 pmol min' mg-1) (P<0.001) (Fig-
ure 1).
Figure 2 shows that the particulate PKC activity was also
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Figure 1 Total protein kinase C activity in normal mucosa and
adenomas in patients with colorectoal carcinoma. The PKC
activity of each sample was assayed as described in Materials and
methods. Individual values are shown, and the thick lines and
bars represent the mean and sd. *P<0.001.
significantly lower in adenomas than in the normal mucosa
(71.4±31.3 vs 115±39.6pmolmin-' mg-') (P<0.001).
The total and particulate PKC activity of both fractions
did not differ with the age and sex of the patients or the
location of the adenoma. When the specific activity ratio
(adenoma/normal mucosa) was evaluated with respect to
adenoma size using linear regression, the particulate fraction
PKC activity ratio was found to decrease significantly as the
adenoma size increased (Figure 3a) (test for association:
P<0.001, test for linear trend: P<0.001), while the cyto-
solic fraction ratio was not significantly altered (Figure 3b).
The relationship of the PKC activity and it's ratio
(adenoma/normal mucosa) to the histological appearance of
the adenomas is shown in Table I. The particulate specific
PKC activity of tubulovillous adenomas was significantly
lower than that of tubular adenomas (55.2 ± 28.7 vs
80.4 ± 29.7) (pmolmin' mg-') (P<0.05), while there was
no significant difference in the cytosolic PKC activity
(55.7 ± 25.4 vs 48.0 ± 26.4) (pmol min-' mg-'). The particu-
late PKC activity ratio (adenoma/normal mucosa) of tubulo-
villous adenomas was significantly lower than that of tubular
adenomas (0.42 ± 0.11 vs 0.77 ± 0.21) (P<0.05), while there
was no significant difference in the cytosolic PKC activity
ratio (0.78 ± 0.21 vs 0.89 ± 0.34).
Table II shows the relationship of the PKC activity and its
ratio to the grade of dysplasia. The particulate specific PKC
activity with severe dysplasia was lower than that of those
with mild dysplasia (55.0 ± 28.1 vs 89.5 ± 33.5) (pmol min-'
mg-') (P<0.05), while the cytosolic PKC activity showed no
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Figure 2 Particulate protein kinase C activity in normal mucosa
and adenomas in patients with colorectal carcinoma. Particulate
PKC activity was assayed as described in Materials and methods.
Individual values are shown, and the thick lines and bars repre-
sent the mean and sd. *P<0.001.
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Table I Relationship of the protein kinase C activity and its ratio (adenoma/normal mucosa) to the adenoma
histological type
Specific PKC activity Ratiob
ofadenoma (pmolmini-mg- )C Cytosolic Particulate
adenomal adenomal
Histological typea Cytotolic Particulate normal mucosa normal mucosa
Tubular adenoma (n = 16) 48.0 ± 26.4 80.4 + 29.7d 0.89 ± 0.34 0.77 ± 0.21e
Tubulovillous adenoma (n = 9) 55.7 ± 25.4 55.2 ± 28.7d 0.78 ± 0.21 0.42 0.1le
'Histological type was defined according to the criteria of Morson. bProtein kinase C activity ratios were
determined for thecytosolic and particulate fractions from adenoma and normalmucosal tissues. 'Thevaluesshown
represent the mean ± sd. de p<o.o5.
Table II Relationship of the protein kinase C activity and its ratio (adenoma/normal mucosa) to the grade of
adenoma dysplasia
Specific PKC activity Ratiob
ofadenoma (pmolmin-'mg-1)c Cytosolic Particulate
adenomal adenomal
Grade ofdysplasia a Cytotolic Particulate normal mucosa normal mucosa
Mild (n = 9) 55.5 ± 31.2 89.5 ± 33.5d 1.02 ± 0.36 0.81 ± 0.21"
Moderate (n = 7) 48.3 ± 29.4 69.0 ± 21.5 0.75 ± 0.26 0.69 + 0.24
Severe (n = 9) 48.0 18.3 55.0 28.Id 0.74 0.17 0.45 0.13e
aGrade of dysplasia was defined according to the criteria of Morson. bProtein kinase C activity ratios were
determined for the cytosolic and particulate fractions ofadenoma and normal mucosal tissues. 'The values shown
represent the mean ± sd. dp<o.05. CP<0.001.
Particulate fraction
0
0
0
a difference between the various degrees of dysplasia (mild:
55.5 ± 31.2, moderate: 48.3 ± 29.4, and severe: 48.0 ± 18.3)
(pmol min-' mg-'). The particulate PKC activity ratio of
adenomas with severe dysplasia was lower than that of those
with mild dysplasia (0.45 ± 0.13 vs 0.81 ± 0.21) (P<0.001),
while the cytosolic ratio of showed no difference between the
various degrees of dysplasia (mild: 1.02 ± 0.36, moderate:
0.75 ± 0.26, and severe: 0.74 ± 0.17).
Discussion
* *0 This study showed that the total PKC activity and the par-
* * ticulate fraction PKC activity of colorectal adenomas was
* * 4_ lower than that of adjacent normal mucosa. The percentage
of PKC activity in the particulate fraction in adenomas was
also lower than in the normal mucosa. These findings
indicate that a greater proportion of the membrane-bound
....... VIIIPK acIvity. waIonreuae In aceom isu com- - -O ~~~~~~~PKC activity was down-regulated in adenoma tissue com- 10 20 30 40 pared with normal colorectal mucosa.
Cytosolic fraction b Down-regulation of PKC has been demonstrated in several
lines ofcultured cells treated with tumour promoting phorbol
esters (Jaken et al., 1981; Rodriguez & Rozengurt, 1984). In
addition, down-regulation of PKC has been demonstrated in
several cell lines transformed by the ras oncogene (Hsiao et
al., 1989). Moreover, cells with PKC down-regulation have
* been shown to be more susceptible to transformation. Kopp
et al. have also reported that the total PKC activity was
significantly reduced in human colorectal carcinomas and
a adenomas as compared to the adjacent normal mucosa, and
that the particulate PKC activity was equally decreased in
these two types of tumours when compared to the adjacent
* 3 .00 * | | normal mucosa. They suggested that alterations within the
0 | protein kinase C pathway occur as an early event in the
adenoma-carcinoma sequence in the intestinal mucosa, and
* that PKC had an important role in epithelial differentiation
* and growth (Kopp et al., 1991). Our finding that PKC
activity was decreased in the particulate fraction of adenoma
tissue, resulting in a decrease in total PKC activity, was
10 20 30 40 consistent with Kopp's data. These studies suggest that
Adenoma size (mm) decreased particulate PKC activity may contribute to the
progression of colorectal carcinogenesis.
Relationship between the PKC activity ratio (adenoma/ Guillem et al. reported that human colonic carcinoma
iucosa) and adenoma size. The particulate a, PKC samples containing a component of benign adenomatous
tio decreased significantly with increasing adenoma size tissue displayed a shift of PKC activity from the cytosolic to
on: P<0.001, linearity: P<0.001), while the cytosolic b, membrane fractions, whereas carcinomas lacking this benign
ved no significant difference. tissue had reduced levels of total PKC activity. Their results
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suggested that the early stages of colonic transformation in
humans may involve the translocation of PKC activity, while
the later stages might be associated with a reduction in total
PKC activity, i.e., down-regulation (Guillem et al., 1987).
However, we did not confirm such a translocation of PKC
activity in adenoma tissue and the reason for this is currently
unclear. In this content, we showed previously that the cell-
ular distribution (% particulate fraction) of PKC activity in
the normal-looking colonic mucosa of patients with colon
cancer was significantly higher than in patients without
cancer, suggesting that the translocation of PKC activity had
already occurred in apparently normal mucosa in the cancer
patients (Sakanoue et al., 1991a). Moreover, Baum et al.
have reported that the initial translocation of PKC activity in
rat colonic tissue occurred prior to the development of overt
tumours (Baum et al., 1990). Several reports have shown that
normal appearing mucosa of carcinoma patients might alter-
nations promoting malignant transformation (Terpstra et al.,
1987).
Extensive pathological research has accumulated evidence
that small adenomas (1-2 cm in diameter) have a low malig-
nant potential, whereas adenomas over 2 cm in diameter
have a much higher rate of malignant transformation, and
has shown that the malignant potential of adenomas with
severe dysplasia is significantly greater than that of those
with mild or moderate dysplasia (Muto et al., 1975; O'Brien
et al., 1990).
In conclusion, we utilised the specific PKC activity ratio
(adenoma/normal mucosa) in the particulate and cytosolic
fractions to assess the relationship between PKC activity and
malignant potential without bias due to individual variations
in activity. Our data showed that a close correlation existed
between a decrease in the particulate PKC activity ratio and
an increase in the risk of malignant transformation, as
predicted by adenoma size, histological type, and degree of
dysplasia. In contrast, the cytosolic ratio did not differ
significantly with any of these three risk factors. These results
suggested a role for down-regulation of particulate PKC in
the progression of colonic tumours which appears to be an
early event in colonic carcinogenesis. Thus, the PKC activity
of colorectal adenomas may potentially be a useful biological
indicator of tumour progression.
We are grateful to Ms. Takegawa for excellent technical assistance.
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